Skip to main content
. 2023 Dec 20;3:188. doi: 10.1038/s43856-023-00423-5

Table 2.

Distribution of full-time sick leave.

Full-time sick leave Full cohort Female Male <50 years ≥50 years
n (%) n (%) n (%) n (%) n (%)
No sick leave 80,863 (91.0) 51,542 (90.3) 29,321 (92.4) 44,356 (91.7) 36,507 (90.3)
<2 weeks 4216 (4.8) 2875 (5.0) 1341 (4.2) 2248 (4.7) 1968 (4.9)
2–4 weeks 1327 (1.5) 918 (1.6) 409 (1.3) 619 (1.3) 708 (1.8)
1–2 months 1070 (1.2) 788 (1.4) 282 (0.9) 525 (1.1) 545 (1.4)
2–4 months 567 (0.6) 413 (0.7) 154 (0.5) 263 (0.5) 304 (0.8)
4–6 months 260 (0.3) 184 (0.3) 76 (0.2) 126 (0.3) 134 (0.3)
6–9 months 169 (0.2) 123 (0.2) 46 (0.1) 88 (0.2) 81 (0.2)
>9 months 120 (0.1) 81 (0.1) 39 (0.1) 46 (0.1) 74 (0.2)
Since test date 226 (0.3) 163 (0.3) 63 (0.2) 108 (0.2) 118 (0.3)
Test negative Test positive
n (%) n (%)
No sick leave 47285 (92.1) 33578 (89.6)
<2 weeks 2972 (5.8) 1244 (3.3)
2–4 weeks 347 (0.7) 980 (2.6)
1–2 months 241 (0.5) 829 (2.2)
2–4 months 192 (0.4) 375 (1.0)
4–6 months 94 (0.2) 166 (0.4)
6–9 months 72 (0.1) 97 (0.3)
>9 months 64 (0.1) 56 (0.1)
Since test date 69 (0.1) 157 (0.4)

Distribution of the amount of full-time sick leave reported by the study cohort >4 weeks after their test date.